G, P., J, M., & V, F. (2018). C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective. Behavioral sciences (Basel, Switzerland), 8(1), . https://doi.org/10.3390/bs8010015
Chicago Style (17th ed.) CitationG, Pentón-Rol, Marín-Prida J, and Falcón-Cama V. "C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective." Behavioral Sciences (Basel, Switzerland) 8, no. 1 (2018). https://doi.org/10.3390/bs8010015.
MLA (9th ed.) CitationG, Pentón-Rol, et al. "C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective." Behavioral Sciences (Basel, Switzerland), vol. 8, no. 1, 2018, https://doi.org/10.3390/bs8010015.